华熙生物：2025年前三季度净利润约2.52亿元

Group 1 - The core viewpoint of the news is that Huaxi Biological has reported a significant decline in its financial performance for the third quarter of 2025, with revenue and net profit both decreasing year-on-year [1] Group 2 - For the first three quarters of 2025, Huaxi Biological's revenue was approximately 3.163 billion yuan, representing a year-on-year decrease of 18.36% [1] - The net profit attributable to shareholders of the listed company was about 252 million yuan, down 30.29% year-on-year [1] - The basic earnings per share were 0.52 yuan, reflecting a decrease of 30.67% compared to the previous year [1] - As of the report date, Huaxi Biological's market capitalization stood at 25.4 billion yuan [2]